Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis

Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disorder that commonly affects women in the reproductive age group. The disorder has features that propose a blend of functional reproductive disorders, such as anovulation and hyperandrogenism, and metabolic disorders, such as hypergly...

Full description

Bibliographic Details
Main Authors: Duaa Fahs, Dima Salloum, Mona Nasrallah, Ghina Ghazeeri
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/9/1559
_version_ 1797602880347176960
author Duaa Fahs
Dima Salloum
Mona Nasrallah
Ghina Ghazeeri
author_facet Duaa Fahs
Dima Salloum
Mona Nasrallah
Ghina Ghazeeri
author_sort Duaa Fahs
collection DOAJ
description Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disorder that commonly affects women in the reproductive age group. The disorder has features that propose a blend of functional reproductive disorders, such as anovulation and hyperandrogenism, and metabolic disorders, such as hyperglycemia, hypertension, and obesity in women. Until today, the three implemented groups of criteria for the diagnosis of PCOS are from the National Institutes of Health (NIH) in the 1990s, Rotterdam 2003, and the Androgen Excess Polycystic Ovary Syndrome 2009 criteria. Currently, the most widely utilized criteria are the 2003 Rotterdam criteria, which validate the diagnosis of PCOS with the incidence of two out of the three criteria: hyperandrogenism (clinical and/or biochemical), irregular cycles, and polycystic ovary morphology. Currently, the anti-Müllerian hormone in serum is introduced as a substitute for the follicular count and is controversially emerging as an official polycystic ovarian morphology/PCOS marker. In adolescents, the two crucial factors for PCOS diagnosis are hyperandrogenism and irregular cycles. Recently, artificial intelligence, specifically machine learning, is being introduced as a promising diagnostic and predictive tool for PCOS with minimal to zero error that would help in clinical decisions regarding early management and treatment. Throughout this review, we focused on the pathophysiology, clinical features, and diagnostic challenges in females with PCOS.
first_indexed 2024-03-11T04:21:43Z
format Article
id doaj.art-f5d16cab65ac4a0d8bc889b81d9587f4
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-11T04:21:43Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-f5d16cab65ac4a0d8bc889b81d9587f42023-11-17T22:45:21ZengMDPI AGDiagnostics2075-44182023-04-01139155910.3390/diagnostics13091559Polycystic Ovary Syndrome: Pathophysiology and Controversies in DiagnosisDuaa Fahs0Dima Salloum1Mona Nasrallah2Ghina Ghazeeri3Department of Obstetrics and Gynecology, Faculty of Medicine, American University of Beirut Medical Center, Beirut P.O. Box 113-6044, LebanonDepartment of Obstetrics and Gynecology, Faculty of Medicine, American University of Beirut Medical Center, Beirut P.O. Box 113-6044, LebanonDivision of Endocrinology and Metabolism, Faculty of Medicine, American University of Beirut Medical Center, Beirut P.O. Box 113-6044, LebanonDepartment of Obstetrics and Gynecology, Faculty of Medicine, American University of Beirut Medical Center, Beirut P.O. Box 113-6044, LebanonPolycystic ovary syndrome (PCOS) is a complex and heterogeneous disorder that commonly affects women in the reproductive age group. The disorder has features that propose a blend of functional reproductive disorders, such as anovulation and hyperandrogenism, and metabolic disorders, such as hyperglycemia, hypertension, and obesity in women. Until today, the three implemented groups of criteria for the diagnosis of PCOS are from the National Institutes of Health (NIH) in the 1990s, Rotterdam 2003, and the Androgen Excess Polycystic Ovary Syndrome 2009 criteria. Currently, the most widely utilized criteria are the 2003 Rotterdam criteria, which validate the diagnosis of PCOS with the incidence of two out of the three criteria: hyperandrogenism (clinical and/or biochemical), irregular cycles, and polycystic ovary morphology. Currently, the anti-Müllerian hormone in serum is introduced as a substitute for the follicular count and is controversially emerging as an official polycystic ovarian morphology/PCOS marker. In adolescents, the two crucial factors for PCOS diagnosis are hyperandrogenism and irregular cycles. Recently, artificial intelligence, specifically machine learning, is being introduced as a promising diagnostic and predictive tool for PCOS with minimal to zero error that would help in clinical decisions regarding early management and treatment. Throughout this review, we focused on the pathophysiology, clinical features, and diagnostic challenges in females with PCOS.https://www.mdpi.com/2075-4418/13/9/1559polycystic ovary syndromediagnostic criteriapathophysiology
spellingShingle Duaa Fahs
Dima Salloum
Mona Nasrallah
Ghina Ghazeeri
Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis
Diagnostics
polycystic ovary syndrome
diagnostic criteria
pathophysiology
title Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis
title_full Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis
title_fullStr Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis
title_full_unstemmed Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis
title_short Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis
title_sort polycystic ovary syndrome pathophysiology and controversies in diagnosis
topic polycystic ovary syndrome
diagnostic criteria
pathophysiology
url https://www.mdpi.com/2075-4418/13/9/1559
work_keys_str_mv AT duaafahs polycysticovarysyndromepathophysiologyandcontroversiesindiagnosis
AT dimasalloum polycysticovarysyndromepathophysiologyandcontroversiesindiagnosis
AT monanasrallah polycysticovarysyndromepathophysiologyandcontroversiesindiagnosis
AT ghinaghazeeri polycysticovarysyndromepathophysiologyandcontroversiesindiagnosis